Tag: Eddingpharm

January 18, 2018

Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China

Amarin (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics, announced that a clinical trial of Vascepa® (icosapent ethyl) capsules in...
March 14, 2017

OncBioMune Announces Term Sheet with EOC Pharma for Development of Telatinib

OncBioMune Pharmaceuticals (OTCQB:OBMP) announced an agreement with EOC Pharma, a U.S. subsidiary of the Chinese pharmaceutical Eddingpharm.